CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026
  1. CFO Spotlights
  2. Profiles
  3. Yu-Ting, Su

Profile

Yu-Ting, Su

Director, chief executive officer and chief financial officer (principal executive, financial and accounting officer), Acro Biomedical Co., Ltd.

A later filing names a successor. First published here October 28, 2026; built from records as of October 28, 2026.

Yu-Ting, Su signed the annual report of Acro Biomedical Co., Ltd. on Form 10-K as Director, chief executive officer and chief financial officer (principal executive, financial and accounting officer), filed February 11, 2026.1 A later filing by Acro Biomedical Co., Ltd., made on September 2, 2026, names Jing-Zhou Chen as its chief financial officer; the record holds no filing that reports the end of Yu-Ting, Su's tenure.

Seats

The seat in the record

CompanyTitle as filedStandingFilings
Acro Biomedical Co., Ltd. (ACBM)
Services-Amusement & Recreation Services
Director, chief executive officer and chief financial officer (principal executive, financial and accounting officer)A later filing names a successor
Jing-Zhou Chen, filed September 2, 2026 (filing)
1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. February 11, 202610-K filed

    Yu-Ting, Su signed the annual report of Acro Biomedical Co., Ltd. on Form 10-K as Director, chief executive officer and chief financial officer (principal executive, financial and accounting officer), filed February 11, 2026.

    /s/ Yu-Ting, Su Director, chief executive officer and February 11, 2026 Yu-Ting, Su chief financial officer (principal executive, financial and accounting officer)

    [1] Annual report on Form 10-K by Acro Biomedical Co., Ltd., filed with the SEC on February 11, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Annual report on Form 10-K, Acro Biomedical Co., Ltd.. U.S. Securities and Exchange Commission, EDGAR, filed February 11, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Yu-Ting, Su wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.